,sacituzumab govitecan,trastuzumab deruxtecan
astrazeneca,daiichi sankyo,gilead sciences
['breast', 'trodelvy', 'destiny-breast04', '$gild']
w fargo: $gild trodelvy's fate in hr+ breast may meet its destiny-breast04 #asco22
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.